Search
Search Results
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
- Subject(s):
- Antiviral Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical -- standards
Drugs, Investigational -- therapeutic use
Hepatitis C, Chronic -- drug therapy
Antiviral Agents -- pharmacokinetics
Drugs, Investigational -- pharmacokinetics
Research Design -- standards
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2017
- Subject(s):
- Antiviral Agents -- therapeutic use
Clinical Trials as Topic
Drug Evaluation, Preclinical
Drugs, Investigational -- therapeutic use
Herpes Labialis -- drug therapy
Herpes Labialis -- prevention & control
Research Design -- standards
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Author(s):
- Earls, Michael J., author
Hearne, Shelley A., author
- Publication:
- [Washington, D.C.] : Trust for America's Health, February 2004
- Subject(s):
- Communicable Disease Control -- organization & administration
Communicable Diseases, Emerging -- epidemiology
Influenza in Birds -- epidemiology
Primary Prevention -- organization & administration
Antiviral Agents -- supply & distribution
Antiviral Agents -- therapeutic use
Disaster Planning -- organization & administration
Disease Outbreaks -- prevention & control
Global Health
Influenza A Virus, H5N1 Subtype -- genetics
Influenza A Virus, H5N1 Subtype -- pathogenicity
Influenza in Birds -- prevention & control
Influenza in Birds -- transmission
Influenza Vaccines -- supply & distribution
Influenza, Human -- epidemiology
Influenza, Human -- immunology
Influenza, Human -- prevention & control
Mass Vaccination
Poultry
Animals
Humans
United States
- Author(s):
- Hamburg, Margaret A., author
Hearne, Shelley A., author
Levi, Jeffrey, author
Elliott, Kim, author
Segal, Laura M., author
Earls, Michael J., author
- Publication:
- [Washington, D.C.] : Trust for America's Health, June 2005
- Subject(s):
- Influenza A virus -- immunology
Influenza, Human -- prevention & control
Antiviral Agents -- therapeutic use
Disaster Planning
Disease Outbreaks -- prevention & control
Global Health
Influenza in Birds -- epidemiology
Influenza Vaccines -- supply & distribution
Influenza, Human -- epidemiology
Influenza, Human -- immunology
Models, Theoretical
Poultry
Swine
Animals
Humans
United States
- Publication:
- Silver Spring, MD : Center for Drug Evaluation and Research, November 2019
- Subject(s):
- Clinical Trials as Topic
Drug Development -- standards
Smallpox -- drug therapy
Smallpox -- prevention & control
Antiviral Agents -- pharmacology
Antiviral Agents -- therapeutic use
Drug Evaluation, Preclinical
Emergencies
Investigational New Drug Application
Models, Animal
Orthopoxvirus
Public Health
Research Design
Safety
Toxicity Tests
Variola virus
Animals
Humans
United States
United States. Department of Health and Human Services.
United States. Food and Drug Administration.
- Author(s):
- Levi, Jeffrey, author
Vinter, Serena, author
Segal, Laura M., author
St. Laurent, Rebecca, author
- Publication:
- Washington, D.C. : Trust for America's Health, October 2009
- Subject(s):
- Disease Outbreaks -- prevention & control
Health Planning -- economics
Health Services Needs and Demand -- trends
Influenza A Virus, H1N1 Subtype
Influenza, Human -- epidemiology
Public Health Administration -- economics
Adult
Aged
Antiviral Agents -- therapeutic use
Antiviral Agents -- supply & distribution
Child
Community Health Services
Disease Outbreaks -- history
Forecasting
Health Personnel
Health Resources -- statistics & numerical data
History, 20th Century
Hospital Bed Capacity -- statistics & numerical data
Influenza A Virus, H1N1 Subtype -- immunology
Influenza Vaccines -- administration & dosage
Influenza Vaccines -- economics
Influenza Vaccines -- supply & distribution
Influenza, Human -- prevention & control
Insurance Coverage
Insurance, Health
Mass Vaccination -- economics
Minority Health
Oseltamivir -- supply & distribution
Oseltamivir -- therapeutic use
Population Surveillance
Pregnancy
Pregnancy Complications, Infectious -- drug therapy
Sick Leave
Surge Capacity -- organization & administration
Zanamivir -- supply & distribution
Zanamivir -- therapeutic use
Humans
United States
- Publication:
- [Bethesda, Md.] : National Institutes of Health, 1984
- Subject(s):
- Epstein-Barr Virus Infections -- prevention & control
Vaccines
Antiviral Agents -- therapeutic use
- Author(s):
- Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author
- Publication:
- Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022
- Subject(s):
- Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States
